Sonali Kochhar to Humans
This is a "connection" page, showing publications Sonali Kochhar has written about Humans.
Connection Strength
0.112
-
COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER). Vaccine. 2021 04 28; 39(18):2504-2505.
Score: 0.007
-
Expecting the unexpected with COVID-19 vaccines. Lancet Infect Dis. 2021 02; 21(2):150-151.
Score: 0.007
-
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines. Vaccine. 2020 09 03; 38(39):6184-6189.
Score: 0.007
-
Planning for COVID-19 vaccines safety surveillance. Vaccine. 2020 09 11; 38(40):6194-6198.
Score: 0.007
-
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines. Vaccine. 2020 07 31; 38(35):5734-5739.
Score: 0.007
-
Ethics of Conducting Clinical Research in an Outbreak Setting. Annu Rev Virol. 2020 09 29; 7(1):475-494.
Score: 0.007
-
Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations. Vaccine. 2019 05 31; 37(25):3267-3277.
Score: 0.007
-
Immunization in pregnancy safety surveillance in low and middle-income countries- field performance and validation of novel case definitions. Vaccine. 2019 05 16; 37(22):2967-2974.
Score: 0.007
-
Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines. Vaccine. 2019 09 10; 37(38):5796-5802.
Score: 0.006
-
Safety assessment of immunization in pregnancy. Vaccine. 2017 12 04; 35(48 Pt A):6469-6471.
Score: 0.006
-
Immunization in pregnancy clinical research in low- and middle-income countries - Study design, regulatory and safety considerations. Vaccine. 2017 12 04; 35(48 Pt A):6575-6581.
Score: 0.006
-
Time for action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind. BMJ Glob Health. 2021 08; 6(8).
Score: 0.002
-
Ethical and policy considerations for COVID-19 vaccination modalities: delayed second dose, fractional dose, mixed vaccines. BMJ Glob Health. 2021 05; 6(5).
Score: 0.002
-
Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group. Nat Med. 2021 04; 27(4):569-570.
Score: 0.002
-
Suitability of databases in the Asia-Pacific for collaborative monitoring of vaccine safety. Pharmacoepidemiol Drug Saf. 2021 07; 30(7):843-857.
Score: 0.002
-
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines. Vaccine. 2020 11 17; 38(49):7702-7707.
Score: 0.002
-
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines. Vaccine. 2020 11 17; 38(49):7708-7715.
Score: 0.002
-
Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development. J Infect Dis. 2020 06 29; 222(2):180-182.
Score: 0.002
-
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines. Vaccine. 2020 07 22; 38(34):5556-5561.
Score: 0.002
-
Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response. Vaccine. 2021 01 03; 39(1):85-120.
Score: 0.002
-
Assessing feasibility of resources at health facilities in Uganda to diagnose pregnancy and neonatal outcomes. Int Health. 2019 03 01; 11(2):128-135.
Score: 0.002
-
Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage. J Clin Pharmacol. 2018 10; 58 Suppl 10:S123-S139.
Score: 0.002
-
Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation. Vaccine. 2017 12 04; 35(48 Pt A):6472-6482.
Score: 0.001
-
Failure to thrive: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine. 2017 12 04; 35(48 Pt A):6483-6491.
Score: 0.001
-
Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 2017 12 04; 35(48 Pt A):6492-6500.
Score: 0.001
-
Neonatal encephalopathy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine. 2017 12 04; 35(48 Pt A):6501-6505.
Score: 0.001
-
Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 2017 12 04; 35(48 Pt A):6506-6517.
Score: 0.001
-
Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine. 2017 12 04; 35(48 Pt A):6518-6528.
Score: 0.001
-
Antenatal bleeding: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2017 12 04; 35(48 Pt A):6529-6537.
Score: 0.001
-
Dysfunctional labor: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2017 12 04; 35(48 Pt A):6538-6545.
Score: 0.001
-
Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2017 12 04; 35(48 Pt A):6546-6554.
Score: 0.001
-
Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2017 12 04; 35(48 Pt A):6555-6562.
Score: 0.001
-
Spontaneous abortion and ectopic pregnancy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 2017 12 04; 35(48 Pt A):6563-6574.
Score: 0.001
-
Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2016 12 01; 34(49):6015-6026.
Score: 0.001